p53 mRNA (Hanmi Pharmaceutical)

N/A

Report date: 2025/07/15 16:52:48

Base Information

Drug Namep53 mRNA (Hanmi Pharmaceutical)
Drug Alias NameLipid nanoparticle (LNP)-encapsulated mRNAHanmi p53 mRNA
ClassificationCell and gene therapy > Gene therapy > mRNACell and gene therapy > Gene therapy > LNP
Mechanisms of ActionTumor protein p53 replacements
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A